Book icon with persian name of Pubnito
  • Store
  • Library
  • Your Cart


    Total Items:0

    View Cart

    Dr. M. lqbal Choudhary

    Dr. M. lqbal Choudhary

    Top selling books

    You may also be interested in these books written by the same author

    Frontiers in Drug Design & Discovery: Volume 11

    available format

    EPUB

    Frontiers in Drug Design & Discovery: Volume 11

    Dr. M. lqbal Choudhary Atta-ur-Rahman

    $ 69.00

    Most Popular

    Frontiers in Drug Design & Discovery: Volume 11

    Frontiers in Drug Design & Discovery Volume 11 Frontiers in Drug Design and Discovery is a book series devoted to publishing the latest and the most important advances in drug design and discovery. Eminent scientists have contributed chapters focused on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, and structure-activity relationships. This book series should prove to be of interest to all pharmaceutical scientists who are involved in research in drug design and discovery and who wish to keep abreast of rapid and important developments in the field. Volume 11 of this series brings together reviews covering immunotherapy of sepsis, new antimalarials, and the medicinal use of onions for respiratory diseases, among other topics. Topics included in this volume are: - Heme-oxygenase and autophagy connected as a cytoprotective mechanism: potential therapeutic target - Development of recombinant therapeutic proteins in animal cells: Challenges and solutions - Artemisinin Analogues as a Novel Class of Antimalarial Agents: Recent Developments, Current Scenario and Future Perspectives - The effects of Allium cepa and their derivatives on respiratory diseases and the possible mechanisms of these effects - Immunotherapy of Sepsis

    Books List

    You may also be interested in the other books in this section
    logo

    English

    Powered by PUBNiTO | © 2024 Notion Wave Inc.